Back
CytomX Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
CTMX
CytomX Therapeutics, Inc.
Last Price:
$5.44
Seasonality Move:
12.07%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTMX is experiencing slight selling pressure.
CytomX Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.43 | Buy |
| 20-day SMA: | 5.6 | Sell |
| 50-day SMA: | 4.83 | Buy |
| 200-day SMA: | 3.21 | Buy |
| 8-day EMA: | 5.35 | Buy |
| 20-day EMA: | 4.4 | Buy |
| 50-day EMA: | 2.62 | Buy |
| 200-day EMA: | 0.82 | Buy |
CytomX Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.19 | Buy |
| Relative Strength Index (14 RSI): | 52.96 | Buy |
| Chaikin Money Flow: | -211910 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.17 - 5.87) | Sell |
| Bollinger Bands (100): | (3.39 - 5.07) | Buy |
CytomX Therapeutics, Inc. Technical Analysis
| Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CytomX Therapeutics, Inc. Stock
Is CytomX Therapeutics, Inc. Stock a Buy?
-
CytomX Therapeutics, Inc. share price is 5.43 while CTMX 8-day simple moving average is 5.43, which is a Buy signal.
-
The stock price of CTMX is 5.43 while CytomX Therapeutics, Inc. 20-day SMA is 5.60, which makes it a Sell.
-
CytomX Therapeutics, Inc. 50-day simple moving average is 4.83 while CTMX share price is 5.43, making it a Buy technically.
-
CTMX stock price is 5.43 and CytomX Therapeutics, Inc. 200-day simple moving average is 3.21, creating a Buy signal.
CTMX Technical Analysis vs Fundamental Analysis
Buy
56
CytomX Therapeutics, Inc. (CTMX)
is a Buy
Is CytomX Therapeutics, Inc. a Buy or a Sell?
-
CytomX Therapeutics, Inc. stock is rated a BuyThe current CytomX Therapeutics, Inc. [CTMX] share price is $5.43. The Score for CTMX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
CytomX Therapeutics, Inc. Stock Info
Market Cap:
920M
Price in USD:
5.43
Share Volume:
1.9M
CytomX Therapeutics, Inc. 52-Week Range
52-Week High:
6.35
52-Week Low:
0.40
Buy
56
CytomX Therapeutics, Inc. (CTMX)
is a Buy
CytomX Therapeutics, Inc. Share Price Forecast
-
What is the CytomX Therapeutics, Inc. stock price today?The CytomX Therapeutics, Inc. stock price is 5.43 USD today.
-
Will CTMX stock go up or go down?CytomX Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is CytomX Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CytomX Therapeutics, Inc. is not overvalued.
Is CytomX Therapeutics, Inc. Stock a Buy?
-
CytomX Therapeutics, Inc. share price is 5.43 while CTMX 8-day exponential moving average is 5.35, which is a Buy signal.
-
The stock price of CTMX is 5.43 while CytomX Therapeutics, Inc. 20-day EMA is 4.40, which makes it a Buy.
-
CytomX Therapeutics, Inc. 50-day exponential moving average is 2.62 while CTMX share price is 5.43, making it a Buy technically.
-
CTMX stock price is 5.43 and CytomX Therapeutics, Inc. 200-day simple moving average is 0.82, creating a Buy signal.
Fundamental Analysis of CytomX Therapeutics, Inc.
Is CytomX Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.03 per share.
Technical Analysis of CytomX Therapeutics, Inc.
Should I short CytomX Therapeutics, Inc. stock?
-
CTMX Moving Average Covergence Divergence (MACD) indicator is 1.19, suggesting CytomX Therapeutics, Inc. is a Buy
-
CytomX Therapeutics, Inc. Relative Strength Index (RSI) is 52.96, which suggest CytomX Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for CytomX Therapeutics, Inc. is (5.17 - 5.87), which suggest CytomX Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for CytomX Therapeutics, Inc. is (3.39 - 5.07), which suggest CytomX Therapeutics, Inc. is a Buy
* CytomX Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.